Journal
PARASITOLOGY TODAY
Volume 16, Issue 2, Pages 71-74Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S0169-4758(99)01544-6
Keywords
-
Categories
Ask authors/readers for more resources
The widespread use of mebendazole and albendazole for treating intestinal nematode infections in human populations is raising concerns that careful monitoring procedures should be in place to identify any emergence of drug resistance. In this article, Andy Bennett and Helen Guyatt discuss whether benchmark parasitological drug efficacy rates can be defined for these anthelmintics, by analysing published data on cure rates and egg reduction rates in the treatment of Ascaris lumbricoides, Trichuris trichiura and hookworm.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available